Lexicon Announces Loan Facility Of $150M With Oxford Finance To Support Sotagliflozin Commercialization
Lexicon Pharmaceuticals Inc (NASDAQ:LXRX) entered into a loan facility with Oxford Finance LLC for $150 million to support commercial preparations and the potential launch of sotagliflozin in heart failure. The loan facility consists of four tranches, each maturing in March 2027. An initial $25 million tranche was funded at closing. The second $25 million tranche…
Benzinga ·
Benzinga
